Title21 Health Solutions is a leading health sciences software company offering end-to-end Electronic Batch Record, Blood & Marrow Transplant, and EQMS solutions. The company's slogan, "Easy-to-use Software Solutions for the Health Sciences," reflects its commitment to user-friendly technology. Established in 2001, Title21 has carved a niche in Data Analytics, Health Care, Information Technology, and the Internet industry. Title21's innovative platform enables a paperless manufacturing environment and ensures compliance with industry protocols. Notable features include support for Manufacturing, ISBT 128 Labeling, Supplies and Reagents, Equipment Maintenance, Chain of Custody, Finished Product Inventory, CIBMTR\AGNIS Integration, Outcomes Analytics, QC\LIMs integration, and more. The company's clientele boasts esteemed organizations such as Mayo Clinic, Memorial Sloan Kettering Cancer Center, Stanford Health Care, Penn Medicine, Fred Hutch Cancer Research Center, and Kaiser Permanente, among others. Although specific details about the company's headquarters, last investment, and last investment investors are currently unavailable, Title21's impressive client base and its comprehensive suite of solutions position it as a promising investment opportunity for venture capitalists seeking exposure to the evolving health sciences software landscape.
There is no investment information
No recent news or press coverage available for Title21 Health Solutions.